AN

Alan Naylor

GL Glaxo Group Limited: 39 patents #2 of 1,368Top 1%
SL Smithkline Beecham Limited: 9 patents #124 of 1,624Top 8%
NA Novartis Ag: 7 patents #589 of 5,128Top 15%
PP Polyactiva Pty: 5 patents #6 of 15Top 40%
BA Bergenbio Asa: 2 patents #8 of 22Top 40%
UL University Of Leeds: 1 patents #50 of 261Top 20%
📍 Harston, GB: #1 of 3 inventorsTop 35%
Overall (All Time): #35,499 of 4,157,543Top 1%
63
Patents All Time

Issued Patents All Time

Showing 1–25 of 63 patents

Patent #TitleCo-InventorsDate
12336991 Factor XIIA inhibitors Helen PHILIPPOU, Richard J. Foster, Colin FISHWICK, Charlotte REVILL, Ian Yule +8 more 2025-06-24
11787906 Biodegradable drug-polymer conjugate Stephen Lonsdale BIRKETT, Andrew Craig Donohue, Asha Marina D'Souza, Sarah Man Yee Ng, Adrian Sulistio +4 more 2023-10-17
11696955 Drug-polymer conjugate Stephen Lonsdale BIRKETT, Andrew Craig Donohue, Asha Marina D'Souza, Sarah Man Yee Ng, Adrian Sulistio +3 more 2023-07-11
11207417 Drug-polymer conjugate Stephen Lonsdale BIRKETT, Andrew Craig Donohue, Asha Marina D'Souza, Sarah Man Yee Ng, Adrian Sulistio +3 more 2021-12-28
10766861 Pharmaceutically active compounds Jason John Shiers, John Paul Watts, Stuart Thomas Onions, Mohammed Abdul Quddus, Joseph Wrigglesworth +2 more 2020-09-08
10758626 Polymer conjugate comprising a bioactive agent Stephen Lonsdale BIRKETT, Andrew Craig Donohue, Asha Marina D'Souza, Sarah Man Yee Ng, Adrian Sulistio +3 more 2020-09-01
10370388 Heterocyclic compounds and methods of their use Thomas David McCarthy 2019-08-06
10336702 Pharmaceutically active compounds Jason John Shiers, John Paul Watts, Stuart Thomas Onions, Mohammed Abdul Quddus, Joseph Wrigglesworth +2 more 2019-07-02
10308628 Heterocyclic compounds and methods for their use Jane Theresa Brown, Thomas David McCarthy, John Paul Watts 2019-06-04
10113033 Polymer conjugate for delivery of a bioactive agent Sarah Man Yee Ng, Andrew Craig Donohue, Russell John Tait, Stephen Lonsdale BIRKETT, Adrian Sulistio +1 more 2018-10-30
10065943 Pyrrolidine derivatives as angiotensin II type 2 antagonists Jane Theresa Brown, Thomas David McCarthy, John Paul Watts 2018-09-04
9714224 Heterocyclic compounds and methods of their use Thomas David McCarthy 2017-07-25
9708275 Heterocyclic compounds and methods for their use Thomas David McCarthy 2017-07-18
9624243 Heterocyclic compounds and methods of their use Thomas David McCarthy 2017-04-18
9624234 Heterocyclic compounds and methods for their use Thomas David McCarthy 2017-04-18
7635701 Pyrimidine derivatives and their use as CB2 modulators Andrew John Eatherton, Gerard Martin Paul Giblin, Richard Howard Green, William Mitchell, Derek Anthony Rawlings +2 more 2009-12-22
7253198 Hydroxyethylamine derivatives for the treatment of Alzheimer's disease Emmanuel Hubert Demont, Andrew Faller, David T. MacPherson, Peter Henry Milner, Sally Redshaw +3 more 2007-08-07
7232821 (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives Gerard Martin Paul Giblin, Adrian Hall, David Nigel Hurst, Ian Reginald Kilford, Xiao Qing Lewell +1 more 2007-06-19
7223772 Pyrazolopyridine derivatives as selective cox-2 inhibitors Ian Baxter Campbell 2007-05-29
7084148 Substituted pyrimidines as selective cyclooxygenase-2 inhibitors Malcolm Clive Carter, Martin Pass, Jeremy Payne, Neil Anthony Pegg 2006-08-01
7074802 Pyrimidine derivatives as selective inhibitors of cox-2 Charles David Hartley, Jeremy Payne, Neil Anthony Pegg, Richard Howard Doughty, deceased 2006-07-11
7056928 Pyrimidine derivatives as selective inhibitors of COX-2 Malcolm Clive Carter, Jeremy Payne, Neil Anthony Pegg 2006-06-06
7026327 Pyrimidine derivatives useful as selective COX-2 inhibitors Jeremy Payne, Neil Anthony Pegg 2006-04-11
6861429 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors Paul John Beswick, Charanjit Bountra, Ian Baxter Campbell, Neil Matthews 2005-03-01
6831097 2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors Paul John Beswick, Ian Baxter Campbell, Neil Mathews 2004-12-14